Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04041037 · ClinicalTrials.gov registry record
The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series
A clinical trial, sponsored by Integra LifeSciences Corporation.
- Terminated
- Registry status
- 2
- Enrollment target
NCT04041037 is a clinical trial that was terminated before completion, run by Integra LifeSciences Corporation. The registered enrollment target is 2 participants.
The verdict
NCT04041037 was terminated before completion, sponsored by Integra LifeSciences Corporation.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
A case series involving the concomitant use of MicroMatrix® and Cytal® Wound Matrix 2-Layer with standard of care negative pressure wound therapy (NPWT) during the management of pilonidal wound healing.
Interventions
- DEVICE Wound Sheet Matrix 2-Layer and Powder Urinary Bladder Matrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-03-26 |
| Est. Completion | 2019-11-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04041037
The ClinicalTrials.gov registry entry for NCT04041037 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Wound Sheet Matrix 2-Layer and Powder Urinary Bladder Matrix is the first listed.
NCT04041037 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04041037 about?
NCT04041037 is a clinical study titled "The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series". A case series involving the concomitant use of MicroMatrix® and Cytal® Wound Matrix 2-Layer with standard of care negative pressure wound therapy (NPWT) during the management of pilonidal wound healing.
What is the current status of trial NCT04041037?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2019-03-26. Estimated completion is 2019-11-05.
What interventions are being tested in trial NCT04041037?
The interventions under investigation include: Wound Sheet Matrix 2-Layer and Powder Urinary Bladder Matrix (DEVICE).
Who is sponsoring clinical trial NCT04041037?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.